"Finish Your Race" to help end acute myeloid leukemia

Article

At age 49, Don Armstrong received a diagnosis of acute myeloid leukemia, an aggressive form of leukemia. Now at age 54, after five rounds of chemotherapy and a stem cell transplantation, he celebrates his "cancerversary" of being in remission for five years, with a pledge to help eradicate the disease.

Armstrong developed the Finish Your Race (www.finishyourrace.com) campaign and committed to run 10 races (five marathons and five half marathons) with Leukemia & Lymphoma Society's Team in Training program this year. He started in February and will finish up in December. His goal, in addition to running nearly 200 miles, is to raise half a million dollars for the LLS (you can check out his fundraising progress here). He also hopes to raise awareness of blood cancers and support patient services programs.He began his marathon of marathons in his hometown of Fort Worth, Texas. A couple of weeks ago, he finished the marathon in Columbus, Ohio. Next stop is San Diego. The farthest he's traveled for a marathon this year is Paris, France.To help him reach his goal of half a million dollars, Armstron is up for a $250,000 grant from the Pepsi Refresh Project.

This is a similar grant contest that Drew Brees, Superbowl-winning quarterback of the New Orleans Saints, won for his city's ACS Hope Lodge ("Congratulations, Drew Brees"). If Armstrong is one of the top two vote getters by May 31, he'll be awarded half of his goal.

"That's a big deal. All $250,000 will go through Finish Your Race to the Leukemia & Lymphoma Society," he says. "It's really exciting to me to be involved in funding a research project to help future patients, in terms of diagnosis and treatment, and hopefully eliminating the disease in the future."

I have a cousin who is training for the Team in Training marathon in San Diego. I've been receiving updates for the past year on her upcoming marathon and fundraising, sending her encouraging notes, and marveling at all she's accomplished. I'm so impressed by all she's done to prepare for this one marathon and the money she's raised for LLS. And she's running ONE. Armstrong is running 10. It certainly puts it into perspective for me.I've also learned about all the hard work that goes into training for a single marathon--four to five months of structured training offered by Team in Training. Armstrong calls it "taking people from the couch to the finish line."

I'm sure Armstrong has inspired others to commit to their own marathon and fundraising goals for Team in Training--creating a true "pay it forward" effect, benefiting the LLS and blood cancer patients through increased awareness and funding. I'm even starting to feel the bug, from both my cousin and now Armstrong. "You know," Armstrong says, "every day, the people I see inspire me to keep going with my running, so I guess it works both ways."

Related Videos
For patients with cancer, the ongoing chemotherapy shortage may cause some anxiety as they wonder how they will receive their drugs. However, measuring drugs “down to the minutiae of the milligrams” helped patients receive the drugs they needed, said Alison Tray. Tray is an advanced oncology certified nurse practitioner and current vice president of ambulatory operations at Rutgers Cancer Institute in New Jersey.  If patients are concerned about getting their cancer drugs, Tray noted that having “an open conversation” between patients and providers is key.  “As a provider and a nurse myself, having that conversation, that reassurance and sharing the information is a two-way conversation,” she said. “So just knowing that we're taking care of you, we're going to make sure that you receive the care that you need is the key takeaway.” In June 2023, many patients were unable to receive certain chemotherapy drugs, such as carboplatin and cisplatin because of an ongoing shortage. By October 2023, experts saw an improvement, although the “ongoing crisis” remained.  READ MORE: Patients With Lung Cancer Face Unmet Needs During Drug Shortages “We’re really proud of the work that we could do and achieve that through a critical drug shortage,” Tray said. “None of our patients missed a dose of chemotherapy and we were able to provide that for them.” Tray sat down with CURE® during the 49th Annual Oncology Nursing Society Annual Congress to discuss the ongoing chemo shortage and how patients and care teams approached these challenges. Transcript: Particularly at Hartford HealthCare, when we established this infrastructure, our goal was to make sure that every patient would get the treatment that they need and require, utilizing the data that we have from ASCO guidelines to ensure that we're getting the optimal high-quality standard of care in a timely fashion that we didn't have to delay therapies. So, we were able to do that by going down to the minutiae of the milligrams on hand, particularly when we had a lot of critical drug shortages. So it was really creating that process to really ensure that every patient would get the treatment that they needed. For more news on cancer updates, research and education, don’t forget to subscribe to CURE®’s newsletters here.
Yuliya P.L Linhares, MD, an expert on CLL
Yuliya P.L Linhares, MD, and Josie Montegaard, MSN, AGPCNP-BC, experts on CLL
Image of a man with a beard.
Image of a man with gray facial hair and a navy blue suit with a light orange tie.
Image of a woman with black hair.
Related Content